Topics - Cytotoxics and High Potency Manufacturing
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
By Gil Y. Roth
Published October 11, 2011
The CEO of Jubilant HollisterStier talks about integration Read More »
By Gil Roth
Published September 9, 2011
CDMO will exit clinical packaging and semisolids, expand PDS, establish CoE commercial network Read More »
By L. Lee Karras
Published September 7, 2011
The broader implications of Ben Venue exiting the CMO space Read More »
By Tom Patnaik
Published September 7, 2011
Production drives advances in equipment design Read More »
By Gil Roth
Published August 18, 2011
Sterile, cyto manufacturer ends after 70+ years of service Read More »
Published July 7, 2011
Evotec in three-year discovery collaboration with UCB for CNS disorders Read More »
By Frank Generotzky
Published November 9, 2010
What to keep in mind with HPAI Outsourcing Read More »
